Insight into crRNA Processing in Streptococcus mutans P42S and Application of SmutCas9 in Genome Editing
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26052005 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Cas Mosterd und 1 weiteren Autor:innen. Beteiligte Einrichtung: Département de Biochimie, de Microbiologie et de Bio-Informatique, Faculté des Sciences et de Génie, Université Laval, Quebec City, QC G1V 0A6, Canad…. Hauptthemen laut MEDLINE: Streptococcus mutans, Gene Editing, CRISPR-Cas Systems, CRISPR-Associated Protein 9. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council, Natural Sciences and Engineering Research Council of Canada (Discovery Program), T1 Canada Research Chair in Bacteriophages.
Abstract (Originalsprache)
CRISPR-Cas is an adaptive immune system found in bacteria and archaea that provides resistance against invading nucleic acids. Elements of this natural system have been harnessed to develop several genome editing tools, including CRISPR-Cas9. This technology relies on the ability of the nuclease Cas9 to cut DNA at specific locations directed by a guide RNA. In addition, the nuclease activity of Cas9 requires the presence of a short nucleotide motif (5′-NGG-3′ for Cas9 from Streptococcus pyogenes) called PAM, flanking the targeted region. As the reliance on this PAM is typically strict, diverse Cas9 variants recognising different PAM motifs have been studied to target a broader range of genomic sites. In this study, we assessed the potential of Cas9 from Streptococcus mutans strain P42S (SmutCas9) in gene editing. SmutCas9 recognises the rarely targeted 5′-NAA-3′ and 5′-NGAA-3′ PAMs. To test its efficacy, two genes of the virulent lactococcal phage p2 were edited, thereby demonstrating the potential of SmutCas9 for gene editing purposes, particularly in AT-rich genomes. Sequencing of total RNA also revealed the RNA components of this system, allowing further molecular characterisation of the type II-A CRISPR-Cas system of S. mutans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Faculté des Sciences et de Génie, Université Laval, Quebec City, QC G1V 0A6, Canada.
ORCID-Profile: Cas Mosterd, Sylvain Moineau
Förderung
- Natural Sciences and Engineering Research Council
- Natural Sciences and Engineering Research Council of Canada (Discovery Program)
- T1 Canada Research Chair in Bacteriophages
Zitieren
APA
Mosterd, C., & Moineau, S. (2025). Insight into crRNA Processing in Streptococcus mutans P42S and Application of SmutCas9 in Genome Editing. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26052005
Vancouver
Mosterd C, Moineau S. Insight into crRNA Processing in Streptococcus mutans P42S and Application of SmutCas9 in Genome Editing. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26052005
BibTeX
@article{Mosterd2025,
author = {Mosterd, Cas and Moineau, Sylvain},
title = {Insight into crRNA Processing in Streptococcus mutans P42S and Application of SmutCas9 in Genome Editing},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26052005}
}
EUVIMED